Skip to main content

October 2025

Crack GPAT — Prepare for GPAT Online 

Walk in Drive for M.Pharm, B.Pharm, MSc in QA, Manufacturing, Packing, Microbiology at Intas Pharma

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world.
Student Internship Program under SERB at Banaras Hindu University
Bachelors or Masters degree in Zoology / Biochemistry / Biotechnology / Life Science with a minimum of 60% marks
Interview for Production (OSD & Sterile) at Natco Pharma
Supervise production lines, including Granulation, Compression, Coating, and Packing. Good verbal and written English communication skills
V-Ensure Pharma looking for Quality Assurance Manager
V-Ensure Pharma Technologies Pvt Ltd is looking for Passionate and Skilled Professionals to join Growing Team.
Require Packing Junior Operator at Cipla - D.Pharm Apply
Operate & maintain packing machines to achieve quality product & shift wise targeted output with maximum utilisation.
Amneal Pharma Hiring QMS Senior officer
To perform Gap analysis of defined procedures in Batch Manufacturing Record / Batch Packing Record / Standard Operating Procedure / Protocol and initiation of corrective actions. 
Interview for Key Account Manager at Otsuka Pharma
Otsuka Pharmaceutical India Pvt. Ltd. (OPI) is a fully-owned subsidiary of Japanese company, Otsuka Pharmaceutical Factory, Inc. (OPF), Japan.
Walk in Drive for M.Pharm, B.Pharm, MSc in QC, Production at Indoco Remedies
Hands on Experience on, Stability Studies, Analytical Method Validation & Finished Goods.
Opportunity for Pharmacy Graduate as Marketing Professional at UMEDICA
Driving sales to achieve targets and ensuring a healthy P&L for the regional countries. Liaising with clients to ensure optimum inventory levels are maintained to ensure optimum sales are achieved.
Lilly's Oral GLP-1, Orforglipron, Demonstrated Superior Glycemic Control in Two Successful Phase 3 Trials
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials. ACHIEVE-2, the second head-to-head trial in the program, evaluated orforglipron versus dapagliflozin, an SGLT-2 inhibitor, in adults with type 2 diabetes inadequately controlled on metformin.